|
Market Research Report
The Trend Toward Personalized Medicine
|
This publication has been discontinued on July 19, 2011.
Abstract
In This Issue...
In vitro diagnostics (IVD) and molecular diagnostics are multibillion-dollar
industries. Together, they play critical roles in the trend toward
personalized medicine. Pharmaceutical and biotechnology companies are turning
to personalized medicine to help improve the drug development process and
speed the approval of new drugs. In this report, we discuss the role of IVD
and molecular diagnostics in personalized medicine, profile companies in the
field, discuss key trends and issues, and ponder the future of personalized
medicine.
Table of Contents
Introduction
The Role of IVD in Personalized Medicine
- Targeted Cancer Therapies
- Drug-Metabolizing Enzymes
- HIV-Resistance Testing
Diagnostic Companies in Personalized Medicine
- Virco Lab
- Monogram Biosciences
- DakoCytomation
- Vysis
- Genzyme Genetics
- Roche Diagnostics
- Affymetrix
- Third Wave Technologies
Key IVD Trends in Personalized Medicine
- Combination Drug/Diagnostic Products
- Increasing Use of Pharmacogenetic Tests
- Multiplex Testing
Outlook
- Successful Business Models Cost
- Patients' Acceptance of Personalized Medicine
|
